SCHEMBL23965742

SCHEMBL23965742

COCCN(CCOC)c1nc2ccccc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ ALOX15 P16050 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ PPARD Q03181 6/20 0.46
▸ PPARG P37231 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ HTR1A P08908 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR7 P34969 1/20 0.42
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965749 0.93 PPARG (0.53) MEN1KMT2AALOX15TSHRPPARD
SCHEMBL21669173 0.80 SMN1; SMN2 (0.49) MEN1KMT2ASMN1; SMN2LMNANPC1
SCHEMBL21511146 0.79 MEN1 (0.47) MEN1KMT2AALOX15TSHRSMN1; SMN2
SCHEMBL10387972 0.78 CYP3A4 (0.52) MEN1KMT2AALOX15TSHRPPARG
SCHEMBL21675474 0.77 MEN1 (0.46) MEN1KMT2AALOX15TSHRSMN1; SMN2
SCHEMBL18873116 0.77 MEN1 (0.46) MEN1KMT2AALOX15TSHRPPARG
SCHEMBL18997843 0.77 NR1I2 (0.51) MEN1KMT2AALOX15TSHRSMN1; SMN2
SCHEMBL23185838 0.76 KMT2A (0.47) MEN1KMT2AALOX15TSHRSMN1; SMN2
SCHEMBL23016646 0.76 TSHR (0.46) MEN1KMT2AALOX15TSHRSMN1; SMN2
SCHEMBL11750957 0.75 HDAC1 (0.46) ALOX15TSHRPPARDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB MEN1 2649/4885KMT2A 2334/4885ALOX15 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback